These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 22518310)

  • 1. Minimizing hemodialysis catheter dysfunction: an ounce of prevention.
    Lee T; Lok C; Vazquez M; Moist L; Maya I; Mokrzycki M
    Int J Nephrol; 2012; 2012():170857. PubMed ID: 22518310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Citrate versus heparin lock for hemodialysis catheters: a systematic review and meta-analysis of randomized controlled trials.
    Zhao Y; Li Z; Zhang L; Yang J; Yang Y; Tang Y; Fu P
    Am J Kidney Dis; 2014 Mar; 63(3):479-90. PubMed ID: 24125729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel antimicrobial and antithrombotic lock solution for hemodialysis catheters: a multi-center, controlled, randomized trial.
    Maki DG; Ash SR; Winger RK; Lavin P;
    Crit Care Med; 2011 Apr; 39(4):613-20. PubMed ID: 21200319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Taurolidine-based catheter lock regimen significantly reduces overall costs, infection, and dysfunction rates of tunneled hemodialysis catheters.
    Winnicki W; Herkner H; Lorenz M; Handisurya A; Kikić Ž; Bielesz B; Schairer B; Reiter T; Eskandary F; Sunder-Plassmann G; Sengoelge G
    Kidney Int; 2018 Mar; 93(3):753-760. PubMed ID: 28890326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Citrate versus heparin lock for prevention of hemodialysis catheter-related complications: updated systematic review and meta-analysis of randomized controlled trials.
    Mai H; Zhao Y; Salerno S; Li Y; Feng Y; Ma L; Fu P
    Int Urol Nephrol; 2019 Jun; 51(6):1019-1033. PubMed ID: 31012037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of heparin to citrate as a catheter locking solution for non-tunneled central venous hemodialysis catheters in patients requiring renal replacement therapy for acute renal failure (VERROU-REA study): study protocol for a randomized controlled trial.
    Bruyère R; Soudry-Faure A; Capellier G; Binquet C; Nadji A; Torner S; Blasco G; Yannaraki M; Barbar SD; Quenot JP
    Trials; 2014 Nov; 15():449. PubMed ID: 25409678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Locking solutions for hemodialysis catheters; heparin and citrate--a position paper by ASDIN.
    Moran JE; Ash SR;
    Semin Dial; 2008; 21(5):490-2. PubMed ID: 18764795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of tunneled hemodialysis catheter-related infections using catheter-restricted filling with gentamicin and citrate: a randomized controlled study.
    Dogra GK; Herson H; Hutchison B; Irish AB; Heath CH; Golledge C; Luxton G; Moody H
    J Am Soc Nephrol; 2002 Aug; 13(8):2133-9. PubMed ID: 12138146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trisodium citrate 4% versus heparin as a catheter lock for non-tunneled hemodialysis catheters in critically ill patients: a multicenter, randomized clinical trial.
    Quenot JP; Helms J; Bourredjem A; Dargent A; Meziani F; Badie J; Blasco G; Piton G; Capellier G; Mezher C; Rebibou JM; Nadji A; Crepin T; Barbar SD; Fleck C; Cransac A; Boulin M; Binquet C; Soudry-Faure A; Bruyère R;
    Ann Intensive Care; 2019 Jul; 9(1):75. PubMed ID: 31264073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of citrate 4% and heparin as tunneled-catheters-locking solution in chronic hemodialysis].
    Chazot G; Mehdi M; Lorriaux C; Deleaval P; Mayor B; Jean G; Chazot C; Lechevallier S; Moncel O; Vo-Van C; Hurot JM
    Nephrol Ther; 2018 Feb; 14(1):42-46. PubMed ID: 29191576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized trial comparing gentamicin/citrate and heparin locks for central venous catheters in maintenance hemodialysis patients.
    Moran J; Sun S; Khababa I; Pedan A; Doss S; Schiller B
    Am J Kidney Dis; 2012 Jan; 59(1):102-7. PubMed ID: 22088576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized controlled clinical trial of 4% sodium citrate versus heparin as locking solution for temporary dialysis catheters among hemodialysis patients
.
    Abdel Azim ABE; ElSaid TW; El Said HW; Hemida W; Zaghlool S; Ramadan A; Gouda Z; El Masry S; Reda W; Ali HM
    Clin Nephrol; 2018 Nov; 90(5):341-349. PubMed ID: 30148449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does the heparin lock concentration affect hemodialysis catheter patency?
    Ivan DM; Smith T; Allon M
    Clin J Am Soc Nephrol; 2010 Aug; 5(8):1458-62. PubMed ID: 20498241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reevaluation of lock solutions for Central venous catheters in hemodialysis: a narrative review.
    Wang Y; Sun X
    Ren Fail; 2022 Dec; 44(1):1501-1518. PubMed ID: 36047812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sodium citrate 4% versus heparin as a lock solution in hemodialysis patients with central venous catheters.
    Yon CK; Low CL
    Am J Health Syst Pharm; 2013 Jan; 70(2):131-6. PubMed ID: 23292266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Citrate 4% versus heparin and the reduction of thrombosis study (CHARTS).
    Macrae JM; Dojcinovic I; Djurdjev O; Jung B; Shalansky S; Levin A; Kiaii M
    Clin J Am Soc Nephrol; 2008 Mar; 3(2):369-74. PubMed ID: 18308996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodialysis catheter heparin lock related bleeding: Hemorrhagic shock every other day.
    Marques J; Duarte TI; Cotovio P; Borges A; Germano N
    J Vasc Access; 2022 May; 23(3):455-457. PubMed ID: 33570006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodialysis catheter locking solutions and the prevention of catheter dysfunction: a meta-analysis.
    Chapla K; Oza-Gajera BP; Yevzlin AS; Shin JI; Astor BC; Chan MR
    J Vasc Access; 2015; 16(2):107-12. PubMed ID: 25262758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose versus high-dose heparin locks for hemodialysis catheters: a systematic review and meta-analysis.
    Han X; Yang X; Huang B; Yuan L; Cao Y
    Clin Nephrol; 2016 Jul; 86(7):1-8. PubMed ID: 27191662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cefazolin-gentamicin versus taurolidine-citrate for the prevention of infection in tunneled central catheters in hemodialysis patients: A quasi-experimental trial.
    Bueloni TNV; Marchi D; Caetano C; de Souza Cavalcante R; Mendes Amaral ML; Ponce D
    Int J Infect Dis; 2019 Aug; 85():16-21. PubMed ID: 31102823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.